Download these slides for an expert review of the diagnosis and treatment, including current and promising investigational therapies, for chronic spontaneous urticaria.
This program is supported by educational grants from Boehringer Ingelheim Pharmaceuticals, Inc.; Incyte Corporation; Novartis Pharmaceuticals Corporation; and Sanofi and Regeneron Pharmaceuticals.
Jonathan A. Bernstein, MD: consultant/advisor/speaker: AstraZeneca, Genentech, Novartis, Sanofi/Regeneron; researcher: Allakos, Amgen, AstraZeneca, Celldex, Genentech, Sanofi/Regeneron, TLL
© 2022 Practicing Clinicians Exchange. All Rights Reserved. 105822D-PPT2